May 20th- Dr. Minoo Battiwalla- Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network

CME Congresses .

May 20th- Dr. Minoo Battiwalla- Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network

May 12th- Prof. Christian Chabannon - Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

CME Congresses .

May 12th- Prof. Christian Chabannon – Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

April 30th- Dr. Anne-Marie Becking- Zanubrutinib in Bing Neel syndrome: efficacy and tolerability

CME Congresses .

April 30th- Dr. Anne-Marie Becking- Zanubrutinib in Bing Neel syndrome: efficacy and tolerability

April 25th- Dr. Guillermo Manero Garicia-The COMMANDS study from #ASH24

CME Congresses .

April 25th- Dr. Guillermo Manero Garicia-The COMMANDS study from #ASH24

March 25th- Dr. Jian Zhou- Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases

CME Congresses .

March 25th- Dr. Jian Zhou- Luspatercept for the treatment of anemia in allo-HSCT for patients with hematological diseases

March 20th - Dr. Emily Liang- Development and validation of predictive models of early immune effector cell–associated hematotoxicity

CME Congresses .

March 20th Dr. Emily Liang- Development and validation of predictive models of early immune effector cell–associated hematotoxicity

March 4th- Dr. Eli Muchtar- Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

CME Congresses .

March 4th – Dr. Eli Muchtar- Prognostic impact of cytogenetic abnormalities detected by FISH in AL amyloidosis with daratumumab-based frontline therapy

Feb 19th - Prof. Maria Teresa Voso- Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

CME Congresses .

Feb 19th – Prof. Maria Teresa Voso- Acute promyelocytic leukemia: long-term outcomes from the HARMONY project

Feb 9th - Prof. Rahul Banerjee- Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

CME Congresses .

Feb 9th – Prof. Rahul Banerjee- Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis

Feb 3rd- Prof. Ahraf Badros- Daratumumab with Lenalidomide as Maintenance After Transplant in Newly Diagnosed Multiple Myeloma: the AURIGA Study

CME Congresses .

Feb 3rd- Prof. Ahraf Badros- Daratumumab with Lenalidomide as Maintenance After Transplant in Newly Diagnosed Multiple Myeloma: the AURIGA Study